1. Home
  2. Research
  3. Research Groups
  4. Drug utilisation and health outcomes of pharmacotherapy

Drug utilisation and health outcomes of pharmacotherapy

We are a transversal group, we have a wide knowledge and training in relation to pharmacotherapy with a high complexity and specialization. We are experts in the safe and effective use of medicines, applying efficiency and innovation criteria. On the other hand, being a central service, we have experience in process management.

Our clinical areas with greater presence of pharmacists are: elderly patient (geriatrics), infectious (HIV, HCV, HBV, HBV, PROA), hematology, rheumatology, dermatology, neurology and emergency. We offer:

  • Pharmacovigilance, medication safety experience.
  • Knowledge and availability of medications.
  • Data on the use and consumption of medicines.
  • Preparation of drug preparations.
  • Clean rooms.
  • Drug-related technologies.
  • Structure for the management and development of Clinical Trials.
  • Quality Management System Certification.

Search for publications

Only original articles, editorials, guidelines.

  • Rodríguez-Otero N, Fernández-Lozano C, Vicente-Santamaría S, Díaz-Montalvo L, Menéndez-Conde C, Sola-Martínez FJ.

    Rapid drug desensitization protocol in delayed hypersensitivity reactions to CFTR modulator drugs: When everyday counts.

    Journal of investigational allergology & clinical immunology . 34(5): 0-0.

    [doi:10.18176/jiaci.0982]

  • Blanco-Arévalo JL, García-Deltoro M, Torralba M, Vélez-Díaz-Pallarés M, Castro A, Rubio-Rodríguez D, Rubio-Terrés C.

    HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review.

    AIDS REVIEWS . 26(2): 67-79.

    [doi:10.24875/AIDSRev.24000011]

  • Martínez-Moragón E, Antepara Ercoreca I, Muñoz García M, Casas Maldonado F, Calvín Lamas M, Chiner Vives E, Crespo Diz C, Díaz-Pérez D, Eguiluz Gracia I, García Gil S, González-Pérez R, Habernau Mena A, Hermida Valverde T, Jornet Montaña S, López-Carrasco V, Martínez López I, Merino-Bohórquez V, Moreno-Ancillo Á, Mínguez Cabeza AC, Monte-Boquet E, Revuelta-Herrero JL, Sánchez-Cuellar S.

    Patient-reported outcome measures in severe asthma: an expert consensus.

    JOURNAL OF ASTHMA . 61(6): 1-13. Number of citations: 2

    [doi:10.1080/02770903.2023.2297372]

  • Vélez-Díaz-Pallarés M, Delgado-Silveira E, Fernández-Fradejas J, Montero-Llorente B, Palomar-Fernández C, Montero-Errasquín B, Cruz-Jentoft AJ, Álvarez-Díaz A.

    Potentially Inappropriate Prescribing in Older People Living With HIV: A Scoping Review

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 94(5): 445-460.

    [doi:10.1097/QAI.0000000000003298]

  • Esteban-Cartelle B, Serrano DR, Pérez Menéndez-Conde C, Vicente-Oliveros N, Álvarez-Díaz A, Fortún Abete J, Martín-Dávila P.

    Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?

    Microbiology spectrum . 12(1): .

    [doi:10.1128/spectrum.02064-23]

  • Calvin-Lamas M, Calleja Hernández MÁ, Monte-Boquet E, Rodriguez Sagrado MÁ, Ventayol Bosch P.

    [Translated article] Checklist for the pharmaceutical care of patients with interstitial lung disease (CheckEPID): A Delphi-based consensus

    FARMACIA HOSPITALARIA . 47(6): 277-284.

    [doi:10.1016/j.farma.2023.09.004]

  • Delgado-Silveira E, José PB, García MTL, Alonso EAÁ, García MM, Correas FJH.

    [Translated article] Deglufarm: Mobile application with recommendations for the safe administration of drugs in patients with dysphagia or swallowing disorders.

    FARMACIA HOSPITALARIA . 47(6): 285-288.

    [doi:10.1016/j.farma.2023.08.002]

  • Delgado-Silveira E, Bravo José P, Llanos García MT, Álvaro Alonso EA, Muñoz García M, Hidalgo Correas FJ.

    Deglufarm: Mobile application with recommendations for safety drug administration in patients with dysphagia or deglution disorders.

    FARMACIA HOSPITALARIA . 47(6): 285-288.

    [doi:10.1016/j.farma.2023.06.005]

  • Calvin Lamas M, Calleja Hernández MÁ, Monte-Boquet E, Rodriguez Sagrado MÁ, Ventayol Bosch P.

    Checklist for Pharmaceutical Care of the Patient with interstitial lung disease (CheckEPID): A Delphi-based consensus

    FARMACIA HOSPITALARIA . 47(6): 277-284.

    [doi:10.1016/j.farma.2023.06.010]

  • Delgado-Silveira E, Molina Mendoza MD, Montero-Errasquín B, Muñoz García M, Rodríguez Espeso EA, Vélez-Díaz-Pallarés M, Cruz-Jentoft AJ.

    [Spanish version of the STOPP/START 3 criteria: Advances in the detection of inappropriate prescribing medication in the older people].

    Revista espanola de geriatria y gerontologia . 58(5): 101407-101407.

    [doi:10.1016/j.regg.2023.101407]

  • Ojeda IM, Sánchez-Cuervo M, Candela-Toha Á, Serrano-López DR, Bermejo-Vicedo T, Alcaide-López-de-Lerma JM.

    Protocolization of Analgesia and Sedation Through Smart Technology in Intensive Care: Improving Patient Safety.

    CRITICAL CARE NURSE . 43(4): 30-38.

    [doi:10.4037/ccn2023271]

  • García-Ruiz de Morales AG, Martínez-Sanz J, Vivancos-Gallego MJ, Sánchez-Conde M, Vélez-Díaz-Pallarés M, Romero-Hernández B, Vázquez MDG, de Luque CMC, González-Sarria A, Galán JC, Rodríguez FG, Moreno S, Pérez-Elías MJ.

    HIV and HCV screening by non-infectious diseases physicians: can we improve testing and hidden infection rates?

    Frontiers in Public Health . 11: 1136988-1136988.

    [doi:10.3389/fpubh.2023.1136988]

  • Velez-Diaz-Pallares, M, Esteban-Cartelle, B, Gramage-Caro, T, Montero-Llorente, B, Parro-Martin, MD, Rodriguez-Sagrado, MA, Alvarez-Diaz, AM.

    Disorders in sleep quality associated with integrase inhibitors in the treatment of HIV

    REVISTA ESPANOLA DE SALUD PUBLICA . 97: .

  • Vélez-Díaz-Pallarés M, Esteban-Cartelle B, Gramage-Caro T, Montero-Llorente B, Parro-Martín MLÁ, Rodríguez-Sagrado MÁ, Álvarez-Díaz AM.

    Trastornos en la calidad del sueño asociados a los inhibidores de la integrasa en el tratamiento del VIH.

    REVISTA ESPANOLA DE SALUD PUBLICA . 97: .

  • Rosas Cancio-Suárez M, Alonso C, Vivancos MJ, Pérez-Elías MJ, Cárdenas MJ, Vélez-Díaz-Pallarés M, Corbacho MD, Martín-Pedraza L, Muriel A, Martínez-Sanz J, Moreno S.

    Impact of COVID-19 on the Care of Patients with HIV Infection.

    Journal Of Clinical Medicine . 12(12): .

    [doi:10.3390/jcm12123882]

  • Quesada Muñoz L, Fernández-Fradejas J, Martinez-Barros H, Sánchez Cuervo M, Martín Rufo M, Pintor Recuenco MDR, Quereda Rodríguez-Navarro C, Álvarez-Díaz AM, Saez de la Fuente J.

    Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY . 31(6): 532-536.

    [doi:10.1136/ejhpharm-2023-003729]

  • Morillo Verdugo R, Bernardez Ferrán B, Fernández Polo A, Margusino Framiñan L, Martínez Sesmero JM, Velez-Diaz-Pallarés M, Vicente-Escrig E.

    Prioritization of initiatives 2024-2027 of the strategic map of pharmaceutical outpatient care of the Spanish Society of Hospital Pharmacy.

    FARMACIA HOSPITALARIA . : .

    [doi:10.1016/j.farma.2024.03.013]

  • López-Olivencia M, de Pablo R, de Dios NP, García-Plaza S, Sáez-Noguero S, de la Fuente JS, Fortún J, Cuesta MCS.

    The adverse impact of cytomegalovirus infection on intensive care units outcomes in critically ill COVID-19 patients: a single-center prospective observational study.

    Infection . : .

    [doi:10.1007/s15010-025-02499-8]